Indications: LYBALVI® is indicated for the treatment of adults with schizophrenia or bipolar I disorder for acute treatment of manic or mixed episodes as monotherapy and as an adjunct to lithium or valproate, or as a maintenance monotherapy treatment.


Contact Us

Man working in a fish market, holding a tray of ice
Actor portrayal.

If you have questions about LYBALVI, you can reach Alkermes through one of the following options:

Request a Sales Representative

Request an Appointment

Call Us

1-844-LYBALVI (1-844-592-2584),

Monday-Friday 9:00 AM-8:00 PM ET

Write Us

Alkermes, Inc.

852 Winter Street

Waltham, MA 02451

Please include as many details as you can about your questions and how you would like us to contact you in return.

You may report a suspected adverse event related to Alkermes products by calling (888) 235-8008 (United States only) or by emailing us at You are encouraged to report all side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.